Home
Live Updates
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs : vimarsana.com
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
Imugene using MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support azer-cel – a potential first-in-class allogeneic CD19 CAR T product candidate for the treatment of blood...
Related Keywords
United Kingdom ,
Australia ,
North Carolina ,
United States ,
Rockville ,
Western Australia ,
Sydney ,
New South Wales ,
Mary Jane Elliott ,
Panmure Gordon ,
Rupert Dearden ,
David Deuchler ,
Chris Welsh ,
Matt Wright ,
Maher Masoud ,
Youtube Imugenelimited ,
Emma Earl Freddy Crossley ,
Leslie Chong ,
Imugene Limited Contacts ,
Gilmartin Group ,
Maxcyte Inc ,
Linkedin ,
Twitter ,
Nasdaq ,
Linkedin Imugene ,
Flow Electroporation ,
Precision Biosciences ,
Managing Director ,
Cyte Contacts ,
Joint Corporate ,
Limited Contacts ,
Chief Executive ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.